A carregar...
Enhancement of the Replication of Hepatitis C Virus Replicons of Genotypes 1 to 4 by Manipulation of CpG and UpA Dinucleotide Frequencies and Use of Cell Lines Expressing SECL14L2 for Antiviral Resistance Testing
Treatment for hepatitis C virus (HCV) has improved greatly through the use of direct-acting antivirals (DAAs). However, their effectiveness and potential for drug resistance development in non-genotype 1 variants of HCV remain relatively unexplored, as in vitro assays to assess drug susceptibility a...
Na minha lista:
Publicado no: | Antimicrob Agents Chemother |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Microbiology
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862521/ https://ncbi.nlm.nih.gov/pubmed/26953209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02932-15 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|